![[PDF]](/pb-assets/Icons/adobe-pdf-icon-1498649896243.png){kind=icon}
Abstract
Objectives:
We used data from the 2015 National Association of State Alcohol and Drug Abuse Directors Web-based questionnaire and other sources to demonstrate the range and scope of state initiatives being used to deal with the opioid crisis in the United States.
Methods:
State alcohol and drug agency directors and designated senior agency managers responded to the questionnaire, which asked respondents about recent opioid-related state-level public health initiatives at their agencies.
Results:
State alcohol and drug agencies in all 50 states and the District of Columbia responded, all of which reported that prescription drug misuse was a high priority or the highest priority area for their agencies. Of the 51 respondents, states reported initiatives to educate the general public (n = 48), prescribers (n = 31), patients and families (n = 24), and pharmacists (n = 22) about the risks of opioids. In addition, 29 states had increased funding for medication-assisted treatment of opioid addiction, 28 had expanded the availability of naloxone (an opioid antidote), 26 had established guidelines for safe opioid prescribing, 23 had launched requirements for prescriber use of prescription monitoring programs, 23 had passed Good Samaritan laws to protect those helping treat overdoses, and 14 had enacted legislation to regulate pain clinics.
Conclusions:
US state alcohol and drug agencies demonstrated a robust response to the opioid crisis in the United States. They have pursued and expanded on an array of evidence-based initiatives aimed at the opioid crisis. Future public health efforts should focus on maintenance and further expansion of high-quality, evidence-based practices, policies, and programs.
References
| 1. |
Compton, WM, Jones, CM, Baldwin, GT. Relationship between nonmedical prescription-opioid use and heroin use. N Engl J Med. 2016;374(2):154–163. Google Scholar | Crossref | Medline | ISI |
| 2. |
Center for Behavioral Health Statistics and Quality . 2014 National Survey on Drug Use and Health: Detailed Tables. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2015. http://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs2014/NSDUH-DetTabs2014.pdf. Accessed May 31, 2016. Google Scholar |
| 3. |
Jones, CM, Logan, J, Gladden, RM, Bohm, MK. Vital signs: demographic and substance use trends among heroin users—United States, 2002-2013. MMWR Morb Mortal Wkly Rep. 2015;64(26):719–725. Google Scholar | Medline | ISI |
| 4. |
Jones, CM . Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers—United States, 2002-2004 and 2008-2010. Drug Alcohol Depend. 2013;132(1-2):95–100. Google Scholar | Crossref | Medline | ISI |
| 5. |
Muhuri, PK, Gfroerer, JC, Davies, MC; Substance Abuse and Mental Health Services Administration . Associations of nonmedical pain reliever use and initiation of heroin use in the United States. http://www.samhsa.gov/data/sites/default/files/DR006/DR006/nonmedical-pain-reliever-use-2013.htm. Published November 2014. Accessed June 15, 2016. Google Scholar |
| 6. |
Murthy, VH . A promise fulfilled—addressing the nation’s opioid crisis collectively. Public Health Rep. 2016;131(3):387–388. Google Scholar | SAGE Journals |
| 7. |
Substance Abuse and Mental Health Services Administration . Funding and Characteristics of Single State Agencies for Substance Abuse Services and State Mental Health Agencies, 2013. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2015. HHS publication (SMA) 15-4926. http://store.samhsa.gov/shin/content/SMA15-4926/SMA15-4926.pdf. Accessed May 31, 2016. Google Scholar |
| 8. |
National Association of State Alcohol and Drug Abuse Directors . State substance abuse agencies and prescription drug misuse and abuse: results from a NASADAD membership inquiry. http://nasadad.org/wp-content/uploads/2010/12/NASADAD-Report-SSAs-and-Prescription-Drug-Misuse-and-Abuse-09.2012.pdf&hl=en_US. Published September 2012. Accessed June 14, 2016. Google Scholar |
| 9. |
National Association of State Alcohol and Drug Abuse Directors . Overview of state legislation to increase access to treatment for opioid overdose. http://nasadad.org/wp-content/uploads/2015/09/Opioid-Overdose-Policy-Brief-2015-Update-FINAL1.pdf. Published September 2015. Accessed May 20, 2016. Google Scholar |
| 10. |
Rudd, RA, Aleshire, N, Zibbell, JE, Gladden, RM. Increases in drug and opioid overdose deaths—United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016;64(50):1378–1382. Google Scholar | Crossref | Medline |
| 11. |
Nation, M, Crusto, C, Wandersman, A. What works in prevention: principles of effective prevention programs. Am Psychol. 2003;58(6-7):449–456. Google Scholar | Crossref | Medline |
| 12. |
National Institute on Drug Abuse . Drugs, brains, and behavior: the science of addiction. https://teens.drugabuse.gov/sites/default/files/soa_2014.pdf. NIH publication 14-5605. Published April 2007. Revised 2014. Accessed June 14, 2016. Google Scholar |
| 13. |
Substance Abuse and Mental Health Services Administration . Finding interventions to prevent or reduce opioid abuse and overdose: selected resources. http://www.samhsa.gov/capt/sites/default/files/resources/interventions-opioid-overdose.pdf. Published 2014. Accessed May 31, 2016. Google Scholar |
| 14. |
Mack, KA, Jones, CN, Paulozzi, LJ. Vital signs: overdoses of prescription opioid pain relievers and other drugs among women—United States, 1999-2010. MMWR Morb Mortal Wkly Rep. 2013;62(26):537–542. Google Scholar | Medline |
| 15. |
Kilpatrick, DG, Acierno, R, Saunders, B, Resnick, HS, Best, CL, Schnurr, PP. Risk factors for adolescent substance abuse and dependence. J Consult Clin Psychol. 2000;68(1):19–30. Google Scholar | Crossref | Medline |
| 16. |
Stagman, S, Schwarz, SW, Powers, D; National Center for Children in Poverty . Adolescent substance use in the US. http://www.nccp.org/publications/pub_1008.html. Published May 2011. Accessed May 31, 2016. Google Scholar |
| 17. |
Elkington, KS, Bauermeister, JA, Zimmerman, MA. Psychological distress, substance use, and HIV/STI risk behaviors among youth. J Youth Adolesc. 2010;39(5):514–527. Google Scholar | Crossref | Medline |
| 18. |
Substance Abuse and Mental Health Services Administration . Substance Abuse Among Older Adults. Rockville, MD: US Department of Health and Human Services; 1998. HHS publication (SMA) 12-3918. https://www.ncbi.nlm.nih.gov/books/NBK64419/pdf/Bookshelf_NBK64419.pdf. Revised 2012. Accessed June 14, 2016. Google Scholar |
| 19. |
Kolodny, A, Courtwright, DT, Hwang, CS. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health. 2015;36:559–574. Google Scholar | Crossref | Medline | ISI |
| 20. |
Albert, S, Brason, FW, Sanford, CK, Dasgupta, N, Graham, J, Lovette, B. Project Lazarus: community-based overdose prevention in rural North Carolina. Pain Med. 2011;12(suppl 2):S77–S85. Google Scholar | Crossref | Medline |
| 21. |
Dowell, D, Haegerich, TM, Chou, R. CDC guideline for prescribing opioids for chronic pain—United States, 2016 [published erratum appears in MMWR Morb Mortal Wkly Rep. 2016;65(11):295]. MMWR Recomm Rep. 2016;65(1):1–49. Google Scholar | Crossref | Medline |
| 22. |
US Food and Drug Administration . FDA moves quickly to approve easy-to-use nasal spray to treat opioid overdose [news release]. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm473505.htm. Published November 18, 2015. Accessed October 14, 2016. Google Scholar |
| 23. |
Hawk, KF, Vaca, FE, D’Onofrio, G. Reducing fatal opioid overdose: prevention, treatment and harm reduction strategies. Yale J Biol Med. 2015;88(3):235–245. Google Scholar | Medline |
| 24. |
Piper, TM, Stancliff, S, Rudenstine, S. Evaluation of a naloxone distribution and administration program in New York City. Subst Use Misuse. 2008;43(7):858–870. Google Scholar | Crossref | Medline | ISI |
| 25. |
Maxwell, S, Bigg, D, Stanczykiewicz, K, Carlberg-Racich, S. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis. 2006;25(3):89–96. Google Scholar | Crossref | Medline |
| 26. |
Walley, AY, Xuan, Z, Hackman, HH. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:1–12. Google Scholar | Crossref |
| 27. |
Wheeler, E, Davidson, PJ, Jones, TS, Irwin, KS. Community-based opioid overdose prevention programs providing naloxone—United States, 2010. MMWR Morb Mortal Wkly Rep. 2012;61(06):101–105. Google Scholar | Medline |
| 28. |
Centers for Medicare & Medicaid Services . The role of a prescription drug monitoring program in reducing prescription drug diversion, misuse, and abuse. https://www.cms.gov/Medicare-Medicaid-Coordination/Fraud-Prevention/Medicaid-Integrity-Education/Downloads/drugdiversion-drugmonitoring-factsheet.pdf. Published February 2016. Accessed December 6, 2016. Google Scholar |
| 29. |
National Alliance for Model State Drug Laws . Status of prescription monitoring programs. http://www.namsdl.org/library/55F8ABFD-A368-2686-A5B7E9AAABBC27A0. Published 2016. Accessed May 31, 2016. Google Scholar |
| 30. |
National Association of State Controlled Substances Authorities . State profiles. http://www.nascsa.org/stateprofiles.htm. Updated 2015. Accessed May 31, 2016. Google Scholar |
| 31. |
Chakravarthy, B, Shah, S, Lotfipour, S. Prescription drug monitoring programs and other interventions to combat prescription opioid abuse. West J Emerg Med. 2012;13(5):422–425. Google Scholar | Crossref | Medline |
| 32. |
Wixson, SE, Blumenschein, K, Goodin, AJ, Talbert, J, Freeman, PR. Prescription drug monitoring program utilization in Kentucky community pharmacies. Pharm Pract (Granada). 2015;13(2):540. Google Scholar | Crossref | Medline |
| 33. |
Reifler, LM, Droz, D, Bailey, JE. Do prescription monitoring programs impact state trends in opioid abuse/misuse? Pain Med. 2012;13(3):434–442. Google Scholar | Crossref | Medline | ISI |
| 34. |
Baehren, DF, Marco, CA, Droz, DE, Sinha, S, Callan, EM, Akpunonu, P. A statewide prescription monitoring program affects emergency department prescribing behaviors. Ann Emerg Med. 2010;56(1):19–23. Google Scholar | Crossref | Medline |
| 35. |
Paulozzi, LJ, Kilbourne, EM, Desai, HA. Prescription drug monitoring programs and death rates from drug overdose. Pain Med. 2011;12(5):747–754. Google Scholar | Crossref | Medline | ISI |
| 36. |
Kleber, HD . Pharmacologic treatments for opioid dependence: detoxification and maintenance options. Dialogues Clin Neurosci. 2007;9(4):455–470. Google Scholar | Medline |
| 37. |
Fiellin, DA, Friedland, GH, Gourevitch, MN. Opioid dependence: rationale for and efficacy of existing and new treatments. Clin Infect Dis. 2006;43(suppl 4):S173–S177. Google Scholar | Crossref | Medline |
| 38. |
Bart, G . Maintenance medication for opiate addiction: the foundation of recovery. J Addict Dis. 2012;31(3):207–225. Google Scholar | Crossref | Medline |
| 39. |
Krantz, MJ, Mehler, PS. Treating opioid dependence: growing implications for primary care. Arch Intern Med. 2004;164(3):277–288. Google Scholar | Crossref | Medline |
| 40. |
Substance Abuse and Mental Health Services Administration . Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2005. HHS publication (SMA) 12-4214. http://store.samhsa.gov/shin/content//SMA12-4214/SMA12-4214.pdf. Updated 2014. Accessed June 16, 2016. Google Scholar |
| 41. |
Johnson, H, Paulozzi, L, Porucznik, C, Mack, K, Hertner, B. Decline in drug overdose deaths after state policy changes—Florida, 2010-2012. MMWR Morb Mortal Wkly Rep. 2014;63(26):569–574. Google Scholar | Medline | ISI |
| 42. |
Siegler, A, Tuazon, E, O’Brien, BD, Paone, D. Unintentional opioid overdose deaths in New York City, 2005-2010: a place-based approach to reduce risk. Int J Drug Policy. 2014;25(3):569–574. Google Scholar | Crossref | Medline | ISI |
| 43. |
Banta-Green, CJ, Beletsky, L, Schoeppe, JA, Coffin, PO, Kuszler, PC. Police officers’ and paramedics’ experiences with overdose and their knowledge and opinions of Washington State’s drug overdose–naloxone–Good Samaritan law. J Urban Health. 2013;90(6):1102–1111. Google Scholar | Crossref | Medline |
